These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3342098)
1. Effects of verapamil on the cellular accumulations and toxicity of several antitumor drugs in 9-hydroxy-ellipticine-resistant cells. Delaporte C; Charcosset JY; Jacquemin-Sablon A Biochem Pharmacol; 1988 Feb; 37(4):613-9. PubMed ID: 3342098 [TBL] [Abstract][Full Text] [Related]
2. [Cellular resistance to DNA-topoisomerase II inhibitors]. Jacquemin-Sablon A; Bojanowski K; Casabianca-Pignède MR; Crémier S; Delaporte C; Khelifa T; Markovits J; René B; Saucier JM; Larsen AK Bull Cancer; 1994 May; 81(5):381-5. PubMed ID: 7749214 [TBL] [Abstract][Full Text] [Related]
3. Multiple resistance mechanisms in Chinese hamster cells resistant to 9-hydroxyellipticine. Larsen AK; Jacquemin-Sablon A Cancer Res; 1989 Dec; 49(24 Pt 1):7115-9. PubMed ID: 2582453 [TBL] [Abstract][Full Text] [Related]
4. Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: importance of the N-[2(Dimethylamino)ethyl]carbamoyl side chain. Le Mée S; Chaminade F; Delaporte C; Markovits J; Saucier JM; Jacquemin-Sablon A Mol Pharmacol; 2000 Oct; 58(4):709-18. PubMed ID: 10999940 [TBL] [Abstract][Full Text] [Related]
5. Effects of 9-OH-ellipticine on cell survival, macromolecular syntheses, and cell cycle progression in sensitive and resistant Chinese hamster lung cells. Charcosset JY; Bendirdjian JP; Lantieri MF; Jacquemin-Sablon A Cancer Res; 1985 Sep; 45(9):4229-36. PubMed ID: 2992775 [TBL] [Abstract][Full Text] [Related]
6. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors. Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406 [TBL] [Abstract][Full Text] [Related]
7. Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors. Dereuddre S; Delaporte C; Jacquemin-Sablon A Cancer Res; 1997 Oct; 57(19):4301-8. PubMed ID: 9331091 [TBL] [Abstract][Full Text] [Related]
8. Reduced DNA topoisomerase II activity and drug-stimulated DNA cleavage in 9-hydroxyellipticine resistant cells. Charcosset JY; Saucier JM; Jacquemin-Sablon A Biochem Pharmacol; 1988 Jun; 37(11):2145-9. PubMed ID: 2837227 [TBL] [Abstract][Full Text] [Related]
9. Isolation and properties of Chinese hamster lung cells resistant to ellipticine derivatives. Salles B; Charcosset JY; Jacquemin-Sablon A Cancer Treat Rep; 1982 Feb; 66(2):327-38. PubMed ID: 7055817 [TBL] [Abstract][Full Text] [Related]
10. Induction of pgp3 expression and reversion of the multidrug resistance phenotype in 9-OH-ellipticine-resistant Chinese hamster lung fibroblasts transfected with the MYC oncogene. Delaporte C; Dautry F; Jacquemin-Sablon A Biochem Pharmacol; 1997 Jan; 53(1):59-66. PubMed ID: 8960064 [TBL] [Abstract][Full Text] [Related]
11. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Yusa K; Tsuruo T Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930 [TBL] [Abstract][Full Text] [Related]
12. Decreased drug accumulation without increased drug efflux in a novel MRP-overexpressing multidrug-resistant cell line. Gaj CL; Anyanwutaku I; Chang YH; Cheng YC Biochem Pharmacol; 1998 Apr; 55(8):1199-211. PubMed ID: 9719474 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance. Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867 [TBL] [Abstract][Full Text] [Related]
14. [In vitro characterization of S9788, a new modulator of multidrug resistance]. Pérez V; Pierré A; Léonce S; Anstett M; Prost JF; Atassi G Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185 [TBL] [Abstract][Full Text] [Related]
15. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A. Coley HM; Twentyman PR; Workman P Biochem Pharmacol; 1989 Dec; 38(24):4467-75. PubMed ID: 2604747 [TBL] [Abstract][Full Text] [Related]
16. Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line. Gupta RS; Murray W; Gupta R Br J Cancer; 1988 Oct; 58(4):441-7. PubMed ID: 3207599 [TBL] [Abstract][Full Text] [Related]
17. Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates. Rigaudy P; Charcosset JY; Garbay-Jaureguiberry C; Jacquemin-Sablon A; Roques BP Cancer Res; 1989 Apr; 49(7):1836-42. PubMed ID: 2538235 [TBL] [Abstract][Full Text] [Related]
18. Influence of myc overexpression on the phenotypic properties of Chinese hamster lung cells resistant to antitumor agents. Delaporte C; Larsen AK; Dautry F; Jacquemin-Sablon A Exp Cell Res; 1991 Dec; 197(2):176-82. PubMed ID: 1720389 [TBL] [Abstract][Full Text] [Related]
19. Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells. Larsen AK; Paoletti J; Belehradek J; Paoletti C Cancer Res; 1986 Oct; 46(10):5236-40. PubMed ID: 3756875 [TBL] [Abstract][Full Text] [Related]
20. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]